Amferia

About:

Amferia is a startup manufacturing medical materials that actively prevents infections.

Website: https://amferia.com/

Top Investors: Almi Invest, Chalmers Ventures AB, Alexander Hars, Corinthian Properties

Description:

Amferia develops innovative medical devices to provide solutions to the global antibiotic resistance crisis. Amferia’s core focus is preventive healthcare where the goal is to provide highly efficient anti-infective medical devices that can prevent bacterial infections including those caused by antibiotic resistant bacteria. Our dominant focus is within the wound care sector, producing preventive care wound patches for the pressing need to avoid antibiotic resistant skin infections. Amferia’s proprietary anti-infective technology is a result of several years of research from Chalmers University of Technology and is patent protected.

Total Funding Amount:

$3.47M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Mölndal, Vastra Gotaland, Sweden

Founded Date:

2018-01-01

Founders:

Anand Kumar Rajasekharan, Martin Andersson, Saba Atefyekta

Number of Employees:

1-10

Last Funding Date:

2024-09-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai